{
    "clinical_study": {
        "@rank": "31895", 
        "acronym": "PRECON2", 
        "arm_group": [
            {
                "arm_group_label": "Remifentanil", 
                "arm_group_type": "Active Comparator", 
                "description": "Remifentanil the basic opioid drug in anesthesia"
            }, 
            {
                "arm_group_label": "Sufentanil", 
                "arm_group_type": "Active Comparator", 
                "description": "Sufentanil the basic opioid drug in anesthesia"
            }
        ], 
        "brief_summary": {
            "textblock": "To evaluate the effect on cognitive function, recovery, cardioprotection and haemodynamics\n      of standard Remifentanil anaesthesia to standard Sufentanil anaesthesia in patients\n      undergoing coronary artery bypass with or without aortic valve replacement."
        }, 
        "brief_title": "Remifentanil/Sufentanil for CABG+/-AVR Evaluated by Recovery, Cognitive Function, Haemodynamics and Biochemical Markers.", 
        "completion_date": {
            "#text": "February 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Ischaemic Heart Disease", 
            "Aortic Stenosis"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Aortic Valve Stenosis", 
                "Coronary Artery Disease", 
                "Myocardial Ischemia", 
                "Heart Diseases"
            ]
        }, 
        "detailed_description": {
            "textblock": "1. Haemodynamic effects, evaluated by invasive haemodynamic data (arterial line and PAC)\n           of opioid given as single drug and in combination with Propofol (first 30 patients\n           only).\n\n        2. Cognitive dysfunction evaluated by standard test preoperative and postoperative day 1,\n           4 and 30\n\n        3. Recovery quality and time parameters using objective ICU score criteria\n\n        4. Cardioprotection effect evaluated by myocardial biochemical markers obtained\n           preoperative and postoperative 4, 9 and 18 hours"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients scheduled for coronary artery bypass grafting (CABG) +/- aortic valve\n             replacement (AVR)\n\n        Exclusion Criteria:\n\n          -  Ejection Fraction < 30%\n\n          -  Previous Myocardial Infarction within 4 weeks\n\n          -  Severe pulmonary hypertension (mean pulmonary artery pressure (mPAP)  >  33% of mean\n             arterial pressure (MAP)\n\n          -  Arterial hypertension (Sap > 180, Dap > 110)\n\n          -  Diabetes, Non- and Insulin dependent\n\n          -  Non usable echocardiography windows"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "60 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "January 6, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02053818", 
            "org_study_id": "2010-022428-58"
        }, 
        "intervention": [
            {
                "arm_group_label": "Remifentanil", 
                "description": "Randomization to receive Remifentanil (ultrashort acting opioid) as basic opioid in anaesthesia", 
                "intervention_name": "Remifentanil", 
                "intervention_type": "Drug", 
                "other_name": "Ultiva"
            }, 
            {
                "arm_group_label": "Sufentanil", 
                "description": "Randomization to receive Sufentanil (medium/long acting opioid) as basic opioid in anaesthesia", 
                "intervention_name": "Sufentanil", 
                "intervention_type": "Drug", 
                "other_name": "Sufenta"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Anesthetics", 
                "Remifentanil", 
                "Sufentanil"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Cognitive dysfunction", 
            "Cardioprotection", 
            "Recovery", 
            "Renal function", 
            "ICU discharge"
        ], 
        "lastchanged_date": "February 1, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Aarhus N", 
                    "country": "Denmark", 
                    "zip": "8200"
                }, 
                "name": "Aarhus University Hospital"
            }
        }, 
        "location_countries": {
            "country": "Denmark"
        }, 
        "number_of_arms": "2", 
        "official_title": "Fast-track in Cardiac Surgery. Remifentanyl & Sufentanil Anaesthesia for CABG+/-AVR Evaluated by Recovery, Cognitive Dysfunction, Haemodynamics (PAC/TTE) and Cardiac Biochemical Markers (CKMB, TNT, Pro-BNP)", 
        "other_outcome": [
            {
                "description": "Evaluation of haemodynamic indexes (cardiac index, stroke volume index, central venous oxygenation, blood pressure, Heart rate) together with echocardiographic evaluation of systolic and diastolic function.\nEvaluation both by single opioid and combination with propofol", 
                "measure": "Haemodynamic effects of opioids", 
                "safety_issue": "Yes", 
                "time_frame": "From induction anaesthesia until cardiopulmonary bypass"
            }, 
            {
                "description": "Evaluation based on myocardial biochemical markers CK-MB, Troponin-T and Nt-Pro-BNP preoperative and 4, 9 and 15 and 40 hours after surgery", 
                "measure": "Cardioprotection", 
                "safety_issue": "No", 
                "time_frame": "0,4,9,15 and 40 hours after surgery"
            }
        ], 
        "overall_official": {
            "affiliation": "Department of Anaesthesiology and Intensive Care, Aarhus University Hospital", 
            "last_name": "Carl-Johan Jakobsen, MD", 
            "role": "Study Director"
        }, 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": "Denmark: Danish Health and Medicines Authority", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Cognitive function evaluated by Palo Alto Veterans Hospital Test on all patients", 
            "measure": "Cognitive function score", 
            "safety_issue": "No", 
            "time_frame": "Postoperative day 4"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02053818"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Aarhus University Hospital", 
            "investigator_full_name": "Carl-Johan Jakobsen", 
            "investigator_title": "Research Consultant, Ass professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Estimation on hours in ICU before the patients were eligible for discharge from ICU = ICD4 (Total score < 5, and no single score > 2) using an objective ICU score. The ICU score is done each hour after extubation", 
                "measure": "Eligible time to discharge from ICU", 
                "safety_issue": "No", 
                "time_frame": "Time (hours) to ICD4"
            }, 
            {
                "description": "Changes from pre-operative cognitive function to postoperative cognitive function on day 1, 4 and 30 using cognitive function test from Palo Alto Veterans Hospital Test on all patients", 
                "measure": "Postoperative cognitive dysfunction", 
                "safety_issue": "No", 
                "time_frame": "Postoperative day 1 and 30"
            }
        ], 
        "source": "Aarhus University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Aarhus University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}